LRRK2 in Parkinson's disease: genetic and clinical studies from patients.

Abstract excerpt

Mutations in leucine-rich repeat kinase 2 (LRRK2) (PARK8) are associated with both familial and sporadic forms of Parkinson's disease. Most studies have shown that LRRK2 mutations may explain between 5% and 13% of familial and 1-5% of sporadic Parkinson's disease. Importantly, a common recurrent mutation (G2019S) located in the kinase domain has been reported across most ethnic populations, with the highest...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Genetic Testing
• Share to Genotype
• Share to Leucine-Rich Repeat Serine-Threonine Protein Kinase-2